WHWK
Whitehawk Therapeutics Inc NASDAQ Listed Aug 1, 2017$4.18
+0.97%
vs $4.14
Mkt Cap $206.7M
52w Low $1.57
66.5% of range
52w High $5.50
50d MA $4.14
200d MA $3.32
P/E (TTM)
—
EV/EBITDA
—
P/B
1.9x
Debt/Equity
0.0x
ROE
-15.1%
P/FCF
-2.6x
RSI (14)
62.60
ATR (14)
$0.22
Beta
0.62
50d MA
$4.14
200d MA
$3.32
Avg Volume
598.6K
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.
17383 Sunset Blvd, Suite A250 · Pacific Palisades, CA 90272 · US
Data updated apr 27, 2026 9:21am
· Source: financialmodelingprep.com